Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected ChildrenCompleted
NCT00000967Phase 1Updated Oct 29, 2021
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
United States, Puerto Rico
Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.Completed
NCT00000764Phase 1Updated Oct 28, 2021
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections · Anus Neoplasms
United States
Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) ParticipantsTerminated
NCT02792192Phase 1, Phase 2Updated Oct 28, 2021
Sponsor: Hoffmann-La Roche
Bladder Cancer
United States
A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZTCompleted
NCT00000653Phase 2Updated Oct 27, 2021
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
United States, Puerto Rico
A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive IndividualsCompleted
NCT00000648NAUpdated Oct 27, 2021
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections · Neurosyphilis
United States
A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label ExtensionTerminated
NCT03504917Phase 3Updated Oct 27, 2021
Sponsor: Hoffmann-La Roche
Autism Spectrum Disorder
United States, Canada, France, Italy, Spain +1 more
Carboplatin-cyclophosphamide Combined With AtezolizumabCompleted
NCT02914470Phase 1Updated Oct 19, 2021
Sponsor: The Netherlands Cancer Institute
Breast Cancer · Cervix Cancer · Ovarian Cancer · Endometrial Cancer
Netherlands
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the ColonTerminated
NCT00314353Phase 2Updated Oct 6, 2021
Sponsor: NSABP Foundation Inc
Colorectal Neoplasms
United States
Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus ChemotherapyCompleted
NCT03911219N/AUpdated Oct 5, 2021
Sponsor: iOMEDICO AG
Stage IV Non-small Cell Lung Cancer · Extensive-stage Small Cell Lung Cancer · Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC
Germany
A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast CancerUnknown
NCT03655353NAUpdated Sep 29, 2021
Sponsor: Henrik Lindman
HER2-positive Breast Cancer
Sweden
An RCT of Metformin Vs Orlistat in Obese Anovulatory WomenCompleted
NCT00292799NAUpdated Sep 27, 2021
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Anovulation · Obesity
United Kingdom
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Completed
NCT02366143Phase 3Updated Sep 23, 2021
Sponsor: Hoffmann-La Roche
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Austria, Belgium +21 more
¿Can mySugr App Improve Knowledge and Self-management of People With Type 1 Diabetes Mellitus?Completed
NCT03819335NAUpdated Sep 21, 2021
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Diabetes Mellitus, Type 1
Spain
A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast CancerCompleted
NCT02132949Phase 2Updated Sep 17, 2021
Sponsor: Hoffmann-La Roche
Breast Cancer
United States, Canada, Denmark, France, Germany +7 more
HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal BleedingUnknown
NCT04867109N/AUpdated Sep 17, 2021
Sponsor: Nantes University Hospital
Endometrial Neoplasms · Postmenopause · Uterine Hemorrhage · Cancer Biomarker
France
A Study of Subcutaneous Mircera for the Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease Not on DialysisCompleted
NCT00642967Phase 3Updated Sep 14, 2021
Sponsor: Hoffmann-La Roche
Anemia
France
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.Completed
NCT00717821Phase 3Updated Sep 14, 2021
Sponsor: Hoffmann-La Roche
Anemia
France
A French Study to Evaluate the Usefulness of an Implantable Continuous Glucose Monitoring (CGM) Sensor to Improve Glycemic Control in Participants With Diabetes MellitusCompleted
NCT03445065NAUpdated Sep 10, 2021
Sponsor: Hoffmann-La Roche
Diabetes Mellitus
France
European Trial of Immunosuppression in SPK TxCompleted
NCT00140543Phase 3Updated Aug 23, 2021
Sponsor: EUROSPK Study Group
Diabetes Mellitus, Type 1 · Diabetic Nephropathy
Austria, Belgium, Czechia, Germany, Israel +2 more
Participant-Reported Outcomes With the Accu-Chek® Solo Micropump SystemCompleted
NCT03478969NAUpdated Aug 20, 2021
Sponsor: Hoffmann-La Roche
Diabetes Mellitus, Type 1
Austria, Germany, Poland, United Kingdom
A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) InhibitorsCompleted
NCT02165215Phase 3Updated Aug 19, 2021
Sponsor: Hoffmann-La Roche
Colitis, Ulcerative
United States, Brazil, Canada, Czechia, Denmark +10 more
A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) InhibitorsCompleted
NCT02100696Phase 3Updated Aug 13, 2021
Sponsor: Hoffmann-La Roche
Ulcerative Colitis
United States, Argentina, Australia, Austria, Belgium +19 more
Sensitivity of Motor Assessment in MS - a Prospective Cohort StudyUnknown
NCT04993274N/AUpdated Aug 10, 2021
Sponsor: Friedemann Paul
Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis, Secondary Progressive · Multiple Sclerosis, Chronic Progressive
Germany
A Single Ascending Dose Study to Investigate the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Intravenously Administered RO7126209 in Healthy ParticipantsCompleted
NCT04023994Phase 1Updated Aug 9, 2021
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Completed
NCT02367781Phase 3Updated Aug 9, 2021
Sponsor: Hoffmann-La Roche
Carcinoma, Non-Squamous Non-Small Cell Lung
United States, Belgium, Canada, France, Germany +3 more

Previous page Next page